ASF’s 15q Clinical Research Network Offers Q & A on COVID-19 Vaccines

ASF’s 15q Clinical Research Network Offers Q & A on COVID-19 Vaccines

282737

ASF’s 15q Clinical Research Network Offers Q & A on COVID-19 Vaccines

As COVID-19 vaccination programs are being rolled out across the U.S., the Angelman Syndrome Foundation’s 15q Clinical Research Network (CRN) is seeking to address questions and concerns about the vaccines from Angelman syndrome (AS) patients and caregivers. The insight comes from clinicians and Angelman experts at the research network, formed collaboratively by the foundation and the Dup15q Alliance. Angelman syndrome is caused by a missing or malfunctioning UBE3A gene present in the maternal 15q chromosome, and results…

You must be logged in to read/download the full post.